Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

41.

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

N. Engl. J. Med.
Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS.
| Mar 5, 2015
42.

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

Cell.
Montero J, Sarosiek KA, DeAngelo JD, Maertens O, Ryan J, Ercan D, Piao H, Horowitz NS, Berkowitz RS, Matulonis U, Jänne PA, Amrein PC, Cichowski K, Drapkin R, Letai A.
| Feb 26, 2015
43.

Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity.

Nature.
Nuñez JK, Lee AS, Engelman A, Doudna JA.
| Mar 12, 2015
44.

Disease networks. Uncovering disease-disease relationships through the incomplete interactome.

Science.
Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, Barabási AL.
| Feb 20, 2015
46.

Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity.

Proc. Natl. Acad. Sci. U.S.A.
Keskin DB, Reinhold BB, Zhang GL, Ivanov AR, Karger BL, Reinherz EL.
| Feb 17, 2015
47.

Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.

Nature.
Ceccaldi R, Liu JC, Amunugama R, Hajdu I, Primack B, Petalcorin MI, O'Connor KW, Konstantinopoulos PA, Elledge SJ, Boulton SJ, Yusufzai T, D'Andrea AD.
| Feb 12, 2015
48.

EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors.

Nature.
Fillmore CM, Xu C, Desai PT, Berry JM, Rowbotham SP, Lin YJ, Zhang H, Marquez VE, Hammerman PS, Wong KK, Kim CF.
| Apr 9, 2015
49.

Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices.

Proc. Natl. Acad. Sci. U.S.A.
Leshchiner ES, Parkhitko A, Bird GH, Luccarelli J, Bellairs JA, Escudero S, Opoku-Nsiah K, Godes M, Perrimon N, Walensky LD.
| Feb 10, 2015
50.

Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer.

Proc. Natl. Acad. Sci. U.S.A.
Heist RS, Duda DG, Sahani DV, Ancukiewicz M, Fidias P, Sequist LV, Temel JS, Shaw AT, Pennell NA, Neal JW, Gandhi L, Lynch TJ, Engelman JA, Jain RK.
| Feb 3, 2015
51.

Force-dependent transition in the T-cell receptor β-subunit allosterically regulates peptide discrimination and pMHC bond lifetime.

Proc. Natl. Acad. Sci. U.S.A.
Das DK, Feng Y, Mallis RJ, Li X, Keskin DB, Hussey RE, Brady SK, Wang JH, Wagner G, Reinherz EL, Lang MJ.
| Feb 3, 2015
52.

Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche.

Cell.
Tamplin OJ, Durand EM, Carr LA, Childs SJ, Hagedorn EJ, Li P, Yzaguirre AD, Speck NA, Zon LI.
| Jan 15, 2015
53.

Molecular and genetic properties of tumors associated with local immune cytolytic activity.

Cell.
Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N.
| Jan 15, 2015
54.

Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection.

Science.
Penaloza-MacMaster P, Barber DL, Wherry EJ, Provine NM, Teigler JE, Parenteau L, Blackmore S, Borducchi EN, Larocca RA, Yates KB, Shen H, Haining WN, Sommerstein R, Pinschewer DD, Ahmed R, Barouch DH.
| Jan 16, 2015
55.

Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.

Nat. Genet.
Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ, Basom RS, Forouhar M, Gyurkocza B, Schwartz BS, Neistadt B, Marquez R, Mariani CJ, Coats SA, Hofmann I, Lindsley RC, Williams DA, Abkowitz JL, Horwitz MS, King MC, Godley LA, Shimamura A.
| 01 12, 2015
56.

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

N. Engl. J. Med.
Tolaney SM, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis M, Shapira I, Wolff AC, Carey LA, Overmoyer BA, Partridge AH, Guo H, Hudis CA, Krop IE, Burstein HJ, Winer EP.
| Jan 8, 2015
57.

Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARγ effects.

Proc. Natl. Acad. Sci. U.S.A.
Cipolletta D, Cohen P, Spiegelman BM, Benoist C, Mathis D.
| Jan 13, 2015
58.

Intracellular osteopontin regulates homeostasis and function of natural killer cells.

Proc. Natl. Acad. Sci. U.S.A.
Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H.
| Jan 13, 2015
59.

Inducible RNAi in vivo reveals that the transcription factor BATF is required to initiate but not maintain CD8+ T-cell effector differentiation.

Proc. Natl. Acad. Sci. U.S.A.
Godec J, Cowley GS, Barnitz RA, Root DE, Sharpe AH, Haining WN.
| Jan 13, 2015
60.

An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma.

Proc. Natl. Acad. Sci. U.S.A.
Baratta MG, Schinzel AC, Zwang Y, Bandopadhayay P, Bowman-Colin C, Kutt J, Curtis J, Piao H, Wong LC, Kung AL, Beroukhim R, Bradner JE, Drapkin R, Hahn WC, Liu JF, Livingston DM.
| Jan 6, 2015